May 14, 2009 — Lamotrigine (Lamictal, GlaxoSmithKline) orally disintegrating tablets (ODT) have been approved by the US Food and Drug Administration (FDA) for maintenance treatment of bipolar 1 ...
Combining lamotrigine with quetiapine improves the treatment of depressive symptoms in patients with bipolar disorder, with the benefits maintained for at least a year, show findings from the CEQUEL ...
The FDA studies of medications for children and adolescents diagnosed with bipolar disorder have included the age range of 10 to 17 years. Results of the studies have been reported for the patients ...
LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in observational cohorts of people with epilepsy, although the risk did ...
Imagine you, or someone you know, is diagnosed with bipolar disorder. One drug is prescribed, but you have heard another drug is better. What are your next steps? Do you seek evidence? And if so, what ...
A new study found that the drug lamotrigine, used to treat epilepsy and stabilize mood in people with bipolar disorder, worked to stop behaviors like hyperactivity that are linked to autism in mice, ...
Rutgers Health researchers found that lamotrigine, a widely prescribed antiseizure medication, to be safe in older adults with epilepsy, contrary to a safety warning by the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results